PIEVANI, ALICE SILVIA
 Distribuzione geografica
Continente #
NA - Nord America 3.603
AS - Asia 2.141
EU - Europa 2.015
SA - Sud America 319
AF - Africa 52
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 2
Totale 8.140
Nazione #
US - Stati Uniti d'America 3.509
SG - Singapore 806
IT - Italia 571
CN - Cina 523
RU - Federazione Russa 301
HK - Hong Kong 291
DE - Germania 279
BR - Brasile 276
IE - Irlanda 249
SE - Svezia 185
VN - Vietnam 133
GB - Regno Unito 114
ID - Indonesia 77
IN - India 72
CA - Canada 71
UA - Ucraina 68
FI - Finlandia 56
FR - Francia 46
KR - Corea 40
JP - Giappone 36
TR - Turchia 29
ZA - Sudafrica 26
AR - Argentina 22
PK - Pakistan 21
PL - Polonia 21
IR - Iran 20
NL - Olanda 20
BD - Bangladesh 19
MX - Messico 18
ES - Italia 17
AT - Austria 16
DK - Danimarca 15
BE - Belgio 14
IQ - Iraq 14
TW - Taiwan 12
MA - Marocco 9
CH - Svizzera 8
RO - Romania 8
AU - Australia 7
CO - Colombia 7
EG - Egitto 7
LT - Lituania 7
NO - Norvegia 6
PH - Filippine 6
CZ - Repubblica Ceca 5
EC - Ecuador 5
TH - Thailandia 5
AE - Emirati Arabi Uniti 4
IL - Israele 4
KZ - Kazakistan 4
LB - Libano 4
SA - Arabia Saudita 4
AZ - Azerbaigian 3
NP - Nepal 3
PY - Paraguay 3
AL - Albania 2
AM - Armenia 2
CI - Costa d'Avorio 2
JO - Giordania 2
KE - Kenya 2
KG - Kirghizistan 2
PA - Panama 2
PE - Perù 2
RS - Serbia 2
TN - Tunisia 2
VE - Venezuela 2
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
CL - Cile 1
CR - Costa Rica 1
DZ - Algeria 1
EE - Estonia 1
EU - Europa 1
GA - Gabon 1
HN - Honduras 1
HU - Ungheria 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MY - Malesia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
SN - Senegal 1
UG - Uganda 1
UY - Uruguay 1
UZ - Uzbekistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 8.140
Città #
Ann Arbor 534
Singapore 488
Ashburn 386
Hong Kong 288
Dublin 245
Chandler 237
Fairfield 163
Frankfurt am Main 157
Wilmington 154
Milan 148
Houston 146
Woodbridge 143
New York 108
Los Angeles 105
Seattle 99
Beijing 88
Dearborn 80
Santa Clara 71
Jakarta 66
Hefei 62
Shanghai 61
Jacksonville 60
Cambridge 57
Princeton 55
Dallas 50
Ho Chi Minh City 47
Bergamo 43
São Paulo 34
Tokyo 34
Chicago 32
Denver 30
Seoul 29
Nanjing 28
Buffalo 27
Hanoi 27
Helsinki 24
Munich 24
Altamura 23
Rome 23
Lawrence 22
Moscow 22
The Dalles 22
Johannesburg 20
Orem 20
Council Bluffs 18
Lissone 17
Montreal 17
Monza 17
Warsaw 17
London 16
Brussels 14
Turin 14
Portsmouth 13
San Diego 13
Stockholm 13
Carrboro 12
Chennai 12
Nuremberg 12
Toronto 12
Borgomanero 11
Brooklyn 11
Lachine 11
Ottawa 11
Guangzhou 10
Hyderabad 10
Jinan 10
Lappeenranta 10
Poplar 10
Pune 10
Ankara 9
Atlanta 9
Carate Brianza 9
Contursi 9
Lahore 9
Mumbai 9
Nanchang 9
Phoenix 9
San Jose 9
Vienna 9
Belo Horizonte 8
Bologna 8
Hangzhou 8
Hebei 8
Kunming 8
Mexico City 8
Shenyang 8
Turku 8
Baghdad 7
Boardman 7
Brasília 7
Desio 7
Dhaka 7
Florence 7
San Francisco 7
Amsterdam 6
Bergen 6
Brescia 6
Cagliari 6
Changsha 6
Haiphong 6
Totale 5.142
Nome #
Acute myeloid leukaemia niche regulates response to L-asparaginase 408
Mesenchymal stromal cells from Shwachman-Diamond syndrome patients fail to recreate a bone marrow niche in vivo and exhibit impaired angiogenesis 353
Fludarabine as a cost-effective adjuvant to enhance engraftment of human normal and malignant hematopoiesis in immunodeficient mice 325
Acute myeloid leukemia shapes the bone marrow stromal niche in vivo 301
Human umbilical cord blood-borne fibroblasts contain marrow niche precursors that form a bone/marrow organoid in vivo 297
Cytokine-induced killer (cik) cell cultures for the adoptive immunotherapy of hematological malignancies: characterization and new therapeutic strategies for clinical application 294
Location First: Targeting Acute Myeloid Leukemia Within Its Niche 292
Human aplastic anaemia-derived mesenchymal stromal cells form functional haematopoietic stem cell niche in vivo 288
CXCR4-MODIFIED CD33.CAR-CIK WITH ENHANCED BONE MARROW HOMING IN ACUTE MYELOID LEUKEMIA 284
Neonatal combination therapy improves some of the clinical manifestations in the Mucopolysaccharidosis type I murine model 272
Neonatal umbilical cord blood transplantation halts skeletal disease progression in the murine model of MPS-I 240
Selective homing of CAR-CIK cells to the bone marrow niche enhances control of the Acute Myeloid Leukemia burden 237
Catch me if you can: how AML and its niche escape immunotherapy 224
Neonatal bone marrow transplantation prevents bone pathology in a mouse model of mucopolysaccharidosis type I 213
Overexpression of CXCR4 receptor on CD33.CAR-CIK cells enhances the control of the Acute Myeloid Leukemia burden 211
Heterogeneity of the bone marrow niche in patients with myeloproliferative neoplasms: ActivinA secretion by mesenchymal stromal cells correlates with the degree of marrow fibrosis 210
Cellule CD33.CAR-CIK ingegnerizzate per co-esprimere il recettore CXCR4 al fine di aumentare la capacità di migrazione all’interno della nicchia midollare nella leucemia mieloide acuta 205
Cytokine-induced killer cells are terminallydifferentiated activated CD8 cytotoxic T-EMRA lymphocytes 203
Combining the Expression of CD33.CAR and CXCR4 to Increase CAR-CIK Cell Homing to Bone Marrow Niche and Leukemic Stem Cell Eradication in Acute Myeloid Leukemia 202
Comparative analysis of multilineage properties of mesenchymal stromal cells derived from fetal sources shows an advantage of mesenchymal stromal cells isolated from cord blood in chondrogenic differentiation potential 200
Enhanced killing of human B-cell lymphoma targets by combined use of cytokine-induced killer cell (CIK) cultures and anti-CD20 antibodies 197
Overexpression of CXCR4 Enhances the Efficacy of CAR-T Therapy for Acute Myeloid Leukemia 196
Dual-functional capability of CD3 +CD56 + CIK cells, a T-cell subset that acquires NK function and retains TCR-mediated specific cytotoxicity 191
Combining the expression of CD33.CAR and CXCR4 to augment CAR-CIKs homing to bone marrow niche and leukemic stem cell eradication in acute myeloid leukemia 189
Neonatal cellular and gene therapies for mucopolysaccharidoses: the earlier the better? 179
Engineering tandem CD33xCD146 CAR CIK (cytokine-induced killer) cells to target the acute myeloid leukemia niche 177
Generation of CIK cells co-expressing CXCR4 and CD33.CAR with improved homing and antitumor activity for AML 174
Establishment of bone marrow and hematopoietic niches in vivo by reversion of chondrocyte differentiation of human bone marrow stromal cells 173
Feasibility and Safety of Adoptive Immunotherapy with CIK Cells after Cord Blood Transplantation 171
CARs are sharpening their weapons 167
Improving Bone Marrow Homing and Persistence of CD33.CAR-CIK Cells By Overexpression of a Gain-of-Function Variant of CXCR4 to Increase Efficacy in Acute Myeloid Leukemia 164
Bone marrow mesenchymal stromal cells support translation in refractory acute myeloid leukemia 156
AML alters bone marrow stromal cell osteogenic commitment via Notch signaling 146
Ingegnerizzazione di cellule CD33.CAR-CIK con una variante gain-of-function del recettore CXCR4 per aumentarne migrazione e persistenza nella nicchia midollare 144
Modeling skeletal dysplasia in Hurler syndrome using patient-derived bone marrow osteoprogenitor cells 141
A Question of Frame: The Role of the Bone Marrow Stromal Niche in Myeloid Malignancies 130
Bone marrow mesenchymal stromal cells induce nitric oxide synthase-dependent differentiation of CD11b+ cells that expedite hematopoietic recovery 130
CD14 positive cells accelerate hematopoietic stem cell engraftment 127
MPSI Manifestations and Treatment Outcome: Skeletal Focus 92
Harnessing Mesenchymal Stromal Cells for the Engineering of Human Hematopoietic Niches 62
Neonatal gene therapy effectively prevents disease manifestations in a murine model of Mucopolysaccharidosis type I 46
Totale 8.411
Categoria #
all - tutte 28.772
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.772


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021337 0 0 0 0 0 0 57 62 55 75 42 46
2021/2022477 41 36 40 40 36 41 17 16 18 37 37 118
2022/2023896 100 245 56 101 26 126 20 55 71 10 61 25
2023/2024940 42 33 52 65 93 255 142 58 80 28 14 78
2024/20251.734 81 164 169 79 147 135 110 68 152 242 157 230
2025/20262.391 486 237 283 552 582 228 23 0 0 0 0 0
Totale 8.411